Literature DB >> 8640831

Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity.

E Duchaud1, A Ridet, D Stoppa-Lyonnet, N Janin, E Moustacchi, F Rosselli.   

Abstract

Ataxia telangiectasia (AT) is a recessive genetic disease featuring neurodegeneration, immunodeficiency, chromosomal instability, radiation hypersensitivity, and increased predisposition to cancer. Reduced or delayed induction of the tumor suppressor protein p53 after gamma -irradiation was reported. These characteristics may be compatible with an inability to correctly regulate apoptosis. We show here that AT lymphocytes and EBV-transformed lymphoblasts demonstrate a significantly higher level of spontaneous apoptosis, whereas ionizing radiation-induced apoptosis is reduced compared to normal cells. However, neither AT nor normal primary fibroblasts undergo apoptosis after irradiation. Consequently, we conclude that the radiosensitivity of the AT cells is not related to an increased apoptotic response. Finally, we show that SV40-transformed AT fibroblasts undergo gamma- ray-induced apoptosis, while SV40-transformed normal cells do not. This result raises the question of the physiological relevance of the latter cellular model with respect to the AT phenotype.

Entities:  

Mesh:

Year:  1996        PMID: 8640831

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT).

Authors:  R Schubert; J Reichenbach; N Royer; M Pichler; S Zielen
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells.

Authors:  E Fritz; A A Friedl; R M Zwacka; F Eckardt-Schupp; M S Meyn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

Review 3.  Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection.

Authors:  Michel H Bourguignon; Pablo A Gisone; Maria R Perez; Severino Michelin; Diana Dubner; Marina Di Giorgio; Edgardo D Carosella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

4.  Anti-oxidative capacity in patients with ataxia telangiectasia.

Authors:  J Reichenbach; R Schubert; C Schwan; K Müller; H J Böhles; S Zielen
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

5.  Pleiotropic defects in ataxia-telangiectasia protein-deficient mice.

Authors:  A Elson; Y Wang; C J Daugherty; C C Morton; F Zhou; J Campos-Torres; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Elevated Cu/Zn-SOD exacerbates radiation sensitivity and hematopoietic abnormalities of Atm-deficient mice.

Authors:  Y Peter; G Rotman; J Lotem; A Elson; Y Shiloh; Y Groner
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

7.  Analysis of Residual DSBs in Ataxia-Telangiectasia Lymphoblast Cells Initiating Apoptosis.

Authors:  Teresa Anglada; Mariona Terradas; Laia Hernández; Anna Genescà; Marta Martín
Journal:  Biomed Res Int       Date:  2016-01-06       Impact factor: 3.411

8.  Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis.

Authors:  Lan Shao; Hiroshi Fujii; Inés Colmegna; Hisashi Oishi; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Exp Med       Date:  2009-05-18       Impact factor: 14.307

9.  Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1.

Authors:  C Gabellini; A Antonelli; P Petrinelli; A Biroccio; L Marcucci; G Nigro; G Russo; G Zupi; R Elli
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

Review 10.  Ionizing radiation-induced responses in human cells with differing TP53 status.

Authors:  Razmik Mirzayans; Bonnie Andrais; April Scott; Ying W Wang; David Murray
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.